A Case of Advanced Lung Adenocarcinoma Successfully Treated by Intratumoral Injection of Tirelizumab Under Tracheoscopy
Open Access
- 8 August 2025
- journal article
- case report
- Published by Wiley in Cancer Reports
- Vol. 8 (8) , e70279
Abstract
Introduction: Lung cancer is a leading cause of cancer‐related deaths, with an annual mortality rate of nearly 1.8 million. Among its subtypes, lung adenocarcinoma is increasingly prevalent. Due to its often asymptomatic nature, most patients are diagnosed at advanced stages, missing the optimal window for surgery and resulting in a poor 5‐year survival rate.Case Presentation: We present the case of an 83‐year‐old patient with stage IV lung adenocarcinoma treated with four cycles of intravenous Tirelizumab and two cycles of intratumoral Tirelizumab via tracheoscopy. The patient achieved partial clinical remission, with tumor lesions continuing to shrink upon follow‐up by August 24, 2024. No treatment‐related adverse reactions were observed, and the patient's immune function remained normal.Conclusions: This case suggests that systemic intravenous Tirelizumab combined with tracheoscopic intratumoral injection may offer a safe and effective treatment strategy for lung adenocarcinoma, particularly for patients unsuitable for chemotherapy or surgery. However, further prospective studies and clinical trials are needed to validate these findings.Keywords
All Related Versions
Funding Information
- Provincial Secretariat for Science and Technological Development (2020M108)
This publication has 17 references indexed in Scilit:
- Intratumoural administration and tumour tissue targeting of cancer immunotherapiesNature Reviews Clinical Oncology, 2021
- Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancerCochrane Database of Systematic Reviews, 2021
- Clinical effects of cisplatin plus recombinant human endostatin (rh-endostatin) intratumoral injection on malignant central airway obstruction: a retrospective analysis of 319 casesJournal of Thoracic Disease, 2021
- Bronchoscopic intratumoral injections of cisplatin and endostar as concomitants of standard chemotherapy to treat malignant central airway obstructionPostgraduate Medical Journal, 2020
- Bronchoscopic intratumoural therapies for non-small cell lung cancerEuropean Respiratory Review, 2020
- Prospective Multicentered Safety and Feasibility Pilot for Endobronchial Intratumoral ChemotherapyChest, 2019
- Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillanceNature Reviews Clinical Oncology, 2019
- Lipid-Based Nanoparticles: Application and Recent Advances in Cancer TreatmentNanomaterials, 2019
- Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up studyJournal of Thoracic Disease, 2018
- Pharmacokinetics and safety of paclitaxel delivery into porcine airway walls by a new endobronchial drug delivery catheterRespirology, 2017